Materias dentro de su búsqueda.
Mostrando 3,421 - 3,440 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.81s Limitar resultados
  1. 3421
    “…Here, we review the role of IGF-I in leishmaniasis experimental models and human patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases
  2. 3422
    “…Leishmaniasis is a growing health challenge in many parts of Iran, including Kerman Province. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biodiversity, Leishmania genetic typing and host identification of phlebotomine species in endemic foci of southeastern Iran
  3. 3423
    “…Paromomycin is an aminoglycoside antibiotic approved in 2006 for the treatment of visceral leishmaniasis caused by Leishmania donovani in Southeast Asia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo
  4. 3424
    “…Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
  5. 3425
    “…Leishmaniasis is a zoonosis caused by unicellular protozoans Leishmania. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Kala-Azar: A Case Report
  6. 3426
    “…A high frequency of feline leishmaniasis has been reported in several countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical, hematological, biochemical, and histopathological evaluations in domestic cats (Felis catus) infected by Leishmania infantum
  7. 3427
    “…Leishmaniasis is amongst the most important neglected diseases, afflicting more than 12 million people in 88 countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania
  8. 3428
    “…L. donovani is an intracellular protozoan parasite, that causes visceral leishmaniasis (VL), and consequently, post-kala azar dermal leishmaniasis (PKDL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Rapid diagnosis of Leishmania infection with a portable loop-mediated isothermal amplification device
  9. 3429
    “…In this review, we discussed host immunity to leishmaniasis, various treatment options currently being utilized, and the progress of both immunotherapy and vaccine development strategies used so far in leishmaniasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Leishmania Immunity: Advancing Immunotherapy and Vaccine Development
  10. 3430
    por Segarra, Sergi
    Publicado 2021
    “…Leishmaniasis is an emerging, uncontrolled, and neglected zoonotic disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nutritional Modulation of the Immune Response Mediated by Nucleotides in Canine Leishmaniosis
  11. 3431
    “…Every year, the prevalence of this infectious disease increases, with the appearance of 1.5–2 million new cases of cutaneous leishmaniasis and 500,000 cases of visceral leishmaniasis, endangering approximately 350 million people worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evolution of Acridines and Xanthenes as a Core Structure for the Development of Antileishmanial Agents
  12. 3432
    “…BACKGROUND: Three major forms of human disease, cutaneous leishmaniasis, visceral leishmaniasis and mucocutaneous leishmaniasis, are caused by several leishmanial species whose geographic distribution frequently overlaps. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Detection and Identification of Old World Leishmania by High Resolution Melt Analysis
  13. 3433
    “…BACKGROUND: Nucleic acid amplification tests (NAATs) have proven to be advantageous in the diagnosis of leishmaniases, allowing sensitive diagnosis of: (i) cutaneous leishmaniasis in long duration lesions and (ii) visceral leishmaniasis using a less-invasive sample like peripheral blood, in opposition to tissue aspiration required for parasite demonstration by microscopy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of fluorimetry and direct visualization to interpret results of a loop-mediated isothermal amplification kit to detect Leishmania DNA
  14. 3434
    “…BACKGROUND: Leishmaniasis is one of the most important parasitic diseases in the Golestan Province, northeastern Iran. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Distribution of Leishmania Infection in Humans, Animal Reservoir Hosts and Sandflies in Golestan Province, Northeastern Iran: A Systematic Review and Meta-Analysis
  15. 3435
    “…BACKGROUND: Leishmaniasis defines a cluster of protozoal diseases with diverse clinical manifestations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology
  16. 3436
    “…Leishmaniasis, caused by protozoan parasites of the Leishmania genus, represents an important health problem in many regions of the world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Loop-mediated isothermal amplification (LAMP): An advanced molecular point-of-care technique for the detection of Leishmania infection
  17. 3437
    “…INTRODUCTION: Leishmaniasis Mucosa (LM) is a tropical disease that affects the upper respiratory tract and/or oral mucosa. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Parasitological association between human leishmaniosis mucosa and paracoccidioidomycosis. Case report
  18. 3438
    “…IL-32 expression is reported to be induced in the lesions of patients with American tegumentary leishmaniasis (ATL) by the New World Leishmania spp. that are responsible for causing ATL and visceral leishmaniasis (VL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Critical Overview of Interleukin 32 in Leishmaniases
  19. 3439
    “…Cutaneous leishmaniasis caused by Leishmania (Vianna) braziliensis is a major health problem in the state of Ceará in northeastern Brazil. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Drought, Smallpox, and Emergence of Leishmania braziliensis in Northeastern Brazil
  20. 3440
    por Seifert, Karin
    Publicado 2011
    “…Recent years have seen a significant improvement in available treatment options for leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the treatment of visceral leishmaniasis (VL) in India since 2002. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development
Herramientas de búsqueda: RSS